Portfolio company
Florey Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops engineered probiotics for patients taking antibiotics to protect gut microbiome health and prevent related medical conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Metabogen
This company develops microbiome-based probiotics and pharmaceuticals for the probiotic and pharmaceutical industries to treat various health conditions.
Freya Biosciences
This company develops microbial immunotherapies targeting the vaginal microbiome to treat infertility and other reproductive health conditions for women.
mbiomics
This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.
Resilient Biotics
This company develops microbiome-derived live biotherapeutics to prevent and treat respiratory diseases in livestock and humans.
Nexilico
This company develops a computational discovery platform for precision microbiome engineering to help pharmaceutical firms and healthcare providers design targeted therapies and personalised treatments.
Human Biome
This biotechnology firm develops gut microbiota-based biotherapeutics and fecal microbiota transplantation preparations for medical professionals treating gastrointestinal infections and antibiotic resistance.
Biomesense
This company develops automated biosensors and analytics software for continuous gut microbiome tracking for clinical researchers, biotechnology firms and pharmaceutical organisations.
EnteroBiotix
This biopharmaceutical company develops orally administered microbial therapeutics for patients with gastrointestinal diseases, including irritable bowel syndrome and blood cancers.